Higher 25-hydroxyvitamin D Is Associated with Lower Relapse Risk in Multiple Sclerosis
Steve Simpson, Bruce Taylor, Leigh Blizzard, Anne-Louise Ponsonby, Fotini Pittas, Helen Tremlett, Terence Dwyer, Peter Gies, Ingrid van der Mei
Annals of Neurology | WILEY | Published : 2010
Awarded by National Health and Medical Research Council of Australia
The Multiple Sclerosis Longitudinal Study was funded by a grant from the National Health and Medical Research Council of Australia (Project 211308, Principal investigators: T.D., A-L.P., B.T., P.G.). Additional funding for 25-OH-D measures was provided by the Trish Foundation (Principal investigators: T.D., A-L.P., B.T.).